Regulatory PathRegulatory requirements compared

Active substances

Soya oil + Triglycerides medium chain

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
LIPOFUNDIN MCT-LCT 20% INFUSION100,100 g/l,g/lEmulsion for infusion · Intravenous use1 BottleSAR 64.25Generic · PrescriptionB. BRAUNValid
LIPOFUNDIN MCT-LCT 20% Infusion*100,100 g/l,g/lEmulsion for infusion · Intravenous use1 BottleSAR 103.10Generic · PrescriptionB. BRAUNValid
LIPOFUNDIN MCT-LCT 20% Infusion*100,100 g/l,g/lEmulsion for infusion · Intravenous use1 BottleSAR 42.75Generic · PrescriptionB. BRAUNValid
Indications — CHI Daman Drug Formulary

ACUTE PANCREATITIS

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.